Trials / Active Not Recruiting
Active Not RecruitingNCT02404688
Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition
- Status
- Active Not Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Yale University · Academic / Other
- Sex
- All
- Age
- 21 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The overarching goal of this study is to characterize the effects of ethanol and cannabinoids on simulated driving and related cognition.
Detailed description
To study the effects of ethanol clamped at BAC 0.04% and THC (1.05 mg in a 70 kg individual) on driving.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Active delta-9-THC | Low dose (0.015 mg/kg = 1.05 mg in a 70 kg individual) THC, dissolved in alcohol. This dose is roughly equivalent to smoking approximately 1/4 of a marijuana cigarette, or "joint". Administered over 20 minutes. |
| DRUG | Placebo | Control: small amount of alcohol (quarter teaspoon), with no THC. Administered over 20 minutes. |
| DRUG | Active Ethanol | Target BrAC of 0.04% reached over 20 minutes and then clamped to maintain this dose for an additional 60 minutes. This dose is equivalent to consuming approximately 2 drinks over 1 hour. Administered over a total of 80 minutes. |
| DRUG | Placebo | Control: no alcohol, administered for a total of 80 minutes. |
Timeline
- Start date
- 2015-12-01
- Primary completion
- 2025-12-01
- Completion
- 2025-12-01
- First posted
- 2015-03-31
- Last updated
- 2025-04-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02404688. Inclusion in this directory is not an endorsement.